Premium
A flare of pre‐existing erythema multiforme following BNT162b2 (Pfizer–BioNTech) COVID‐19 vaccine
Author(s) -
Lavery M. J.,
Nawimana S.,
Parslew R.,
Stewart L.
Publication year - 2021
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/ced.14714
Subject(s) - medicine , covid-19 , erythema multiforme , dermatology , virology , disease , outbreak , infectious disease (medical specialty)